相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating CD36 is increased in hyperlipidemic mice: Cellular sources and triggers of release
Sudipta Biswas et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
Christa Buechler et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases
JianPing Wu et al.
DISEASE MARKERS (2020)
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis
Lei Zhao et al.
JOURNAL OF HEPATOLOGY (2018)
HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
Qing Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls
S. Heeboll et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Fatty acid translocase promoted hepatitis B virus replication by upregulating the levels of hepatic cytosolic calcium
Jian Huang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Porphyromonas gingivalis infected macrophages upregulate CD36 expression via ERK/NF-κB pathway
Dong-Yu Liang et al.
CELLULAR SIGNALLING (2016)
Systemic Inflammation in Decompensated Cirrhosis: Characterization and Role in Acute-on-Chronic Liver Failure
Joan Claria et al.
HEPATOLOGY (2016)
Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
Henning Gronbaek et al.
JOURNAL OF HEPATOLOGY (2016)
Metabolic characterization of the natural progression of chronic hepatitis B
Johannes C. Schoeman et al.
GENOME MEDICINE (2016)
Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle
Jian Huang et al.
PLOS ONE (2016)
CD36 is a co-receptor for hepatitis C virus E1 protein attachment
Jun-Jun Cheng et al.
SCIENTIFIC REPORTS (2016)
Acute-on-chronic liver failure
William Bernal et al.
LANCET (2015)
The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment
Hongde Li et al.
SCIENTIFIC REPORTS (2015)
Puerarin Inhibits oxLDL-Induced Macrophage Activation and Foam Cell Formation in Human THP1 Macrophage
Heng Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans
Callie M. Gustafson et al.
BIOLOGY OF SEX DIFFERENCES (2015)
Soluble CD163, a Macrophage Activation Marker, Is Independently Associated With Fibrosis in Patients With Chronic Viral Hepatitis B and C
Konstantin Kazankov et al.
HEPATOLOGY (2014)
The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans
Luis Chavez-Sanchez et al.
HUMAN IMMUNOLOGY (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
The validity of serum markers for fibrosis staging in chronic hepatitis B and C
J. Li et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS
Shili Chen et al.
ELECTROPHORESIS (2013)
Differential Regulation of Host Genes Including Hepatic Fatty Acid Synthase in HBV-Transgenic Mice
Hongmin Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease
Takashi Himoto et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
Rossella Liani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Acute-on-chronic liver failure in chronic hepatitis B
Wai-Kay Seto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population
A. Handberg et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo
Frank Tacke
FIBROGENESIS & TISSUE REPAIR (2012)
The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles
M. J. Alkhatatbeh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis
Henning W. Zimmermann et al.
PLOS ONE (2010)
Cellular fatty acid uptake: a pathway under construction
Xiong Su et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
Giovanna Fattovich et al.
JOURNAL OF HEPATOLOGY (2008)
Role of Human CD36 in Bacterial Recognition, Phagocytosis, and Pathogen-Induced JNK-Mediated Signaling
Irina N. Baranova et al.
JOURNAL OF IMMUNOLOGY (2008)
The metabolovirus model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon
Amir Shlomai et al.
MEDICAL HYPOTHESES (2008)
Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARγ
Kock Hwan Kim et al.
GASTROENTEROLOGY (2007)
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics
P Ventura et al.
LIVER INTERNATIONAL (2005)
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes
MJ Sampson et al.
ATHEROSCLEROSIS (2003)
分享论文
